Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Introduction | 6 | 1 |
| Global Markets Direct Report Coverage | 6 | 1 |
| Equine Encephalitis Overview | 7 | 1 |
| Therapeutics Development | 8 | 2 |
| Pipeline Products for Equine Encephalitis Overview | 8 | 1 |
| Pipeline Products for Equine Encephalitis Comparative Analysis | 9 | 1 |
| Equine Encephalitis Therapeutics under Development by Companies | 10 | 1 |
| Equine Encephalitis Therapeutics under Investigation by Universities/Institutes | 11 | 1 |
| Equine Encephalitis Pipeline Products Glance | 12 | 2 |
| Clinical Stage Products | 12 | 1 |
| Early Stage Products | 13 | 1 |
| Equine Encephalitis Products under Development by Companies | 14 | 1 |
| Equine Encephalitis Products under Investigation by Universities/Institutes | 15 | 1 |
| Equine Encephalitis Companies Involved in Therapeutics Development | 16 | 6 |
| Akshaya Bio Inc. | 16 | 1 |
| Altravax, Inc. | 17 | 1 |
| EpiVax, Inc. | 18 | 1 |
| Integrated BioTherapeutics, Inc. | 19 | 1 |
| Karyopharm Therapeutics, Inc. | 20 | 1 |
| Profectus BioSciences, Inc. | 21 | 1 |
| Equine Encephalitis Therapeutics Assessment | 22 | 9 |
| Assessment by Monotherapy Products | 22 | 1 |
| Assessment by Target | 23 | 2 |
| Assessment by Mechanism of Action | 25 | 2 |
| Assessment by Route of Administration | 27 | 2 |
| Assessment by Molecule Type | 29 | 2 |
| Drug Profiles | 31 | 16 |
| DEF-201 Drug Profile | 31 | 2 |
| equine encephalitis vaccine Drug Profile | 33 | 1 |
| equine encephalitis vaccine Drug Profile | 34 | 1 |
| equine encephalitis vaccine Drug Profile | 35 | 1 |
| imatinib mesylate Drug Profile | 36 | 1 |
| Monoclonal Antibodies for Equine Encephalitis and Chikungunya Drug Profile | 37 | 1 |
| Monoclonal Antibody for Venezuelan Equine Encephalitis Drug Profile | 38 | 1 |
| nilotinib Drug Profile | 39 | 1 |
| TSI-GSD-104 Drug Profile | 40 | 1 |
| Vaccine for Western Equine Encephalitis Drug Profile | 41 | 1 |
| venezuelan equine encephalitis vaccine Drug Profile | 42 | 1 |
| Venezuelan equine encephalitis vaccine Drug Profile | 43 | 1 |
| venezuelan equine encephalitis vaccine Drug Profile | 44 | 1 |
| verdinexor Drug Profile | 45 | 1 |
| Westrern Equine Encephalitis Virus Vaccine Drug Profile | 46 | 1 |
| Equine Encephalitis Dormant Projects | 47 | 1 |
| Equine Encephalitis Product Development Milestones | 48 | 2 |
| Featured News &Press Releases | 48 | 1 |
| Dec 09, 2015: Profectus BioSciences Receives $4.6 Million DOD Grant to Develop Vaccine for Western, Eastern, and Venezuelan Equine Encephalitis Viruses | 48 | 1 |
| Dec 09, 2015: Profectus BioSciences Receives $4.6 Million DOD Grant to Develop Vaccine for Western, Eastern, and Venezuelan Equine Encephalitis Viruses | 48 | 2 |
| Appendix | 50 | 2 |
| Methodology | 50 | 1 |
| Coverage | 50 | 1 |
| Secondary Research | 50 | 1 |
| Primary Research | 50 | 1 |
| Expert Panel Validation | 50 | 1 |
| Contact Us | 50 | 1 |
| Disclaimer | 51 | 1 |